Synergistic venetoclax and anti-CD3 therapy for control of alloreactive response in hematopoietic stem cell transplantation
Year: 2025
Type: article
Language: en
Topic: Hematopoietic Stem Cell Transplantation
Authors and affiliations:
raw_author_name: Bettina P. Iliopoulou
raw_affiliation_strings: Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA; Cellular Immune Tolerance Program, Stanford University School of Medicine, Stanford, California, USA
raw_author_name: Shiva Pathak
raw_affiliation_strings: Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA; Cellular Immune Tolerance Program, Stanford University School of Medicine, Stanford, California, USA; Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, California, USA
raw_author_name: Blake Mosher
raw_affiliation_strings: Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA
raw_author_name: Levon Witherspoon
raw_affiliation_strings: Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA
raw_author_name: Alexandra Wells
raw_affiliation_strings: Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA
raw_author_name: Cameron S. Bader
raw_affiliation_strings: Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA; Cellular Immune Tolerance Program, Stanford University School of Medicine, Stanford, California, USA
raw_author_name: Pin-I Chen
raw_affiliation_strings: Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA; Cellular Immune Tolerance Program, Stanford University School of Medicine, Stanford, California, USA
raw_author_name: Nadine Nagy
raw_affiliation_strings: Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA; Cellular Immune Tolerance Program, Stanford University School of Medicine, Stanford, California, USA; Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, California, USA
raw_author_name: Alejandro Villar-Prados
raw_affiliation_strings: Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA
raw_author_name: Kent Jensen
raw_affiliation_strings: Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA; Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, California, USA
raw_author_name: Everett H. Meyer
raw_affiliation_strings: Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA; Cellular Immune Tolerance Program, Stanford University School of Medicine, Stanford, California, USA; Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, California, USA. Electronic address: evmeyer@stanford.edu